Latest S-1 registration statements

ARKO Petroleum Corp. filed an S-1MEF to register an additional 702,777 shares of Class A common stock for its ongoing public offering.

Figure Technology Solutions, Inc. introduces Series A Blockchain Common Stock, convertible to Class A Common Stock, to trade on its Alternative Trading System (ATS) with strict KYC requirements.

HCW Biologics Inc. is offering up to $10 million in common stock and pre-funded warrants to fund its clinical development and operations, while navigating significant financial losses and ongoing legal and regulatory challenges.

zSpace, a provider of augmented and virtual reality educational technology, files an S-1 registration statement for the resale of up to 12.5 million common shares by selling stockholders and seeks to raise up to $24.4 million in additional capital.

Shuttle Pharmaceuticals Holdings, Inc. is offering up to 2,229,300 shares of common stock and pre-funded warrants to raise capital, signaling a strategic shift to AI-driven drug discovery following the acquisition of Molecule.ai and the discontinuance of its clinical trials.

Grayscale Sui Trust (SUI) filed an S-1/A, detailing its planned conversion to a staking ETF and listing on NYSE Arca, while disclosing financial performance and significant risks.

T3 Defense Inc. (formerly Nukkleus Inc.) has completed a strategic transformation from financial technology to aerospace and defense, marked by several acquisitions and a significant capital raise.

Envoy Medical, Inc. has filed an S-1MEF registration statement to offer an additional $13,437,500 in common stock and various warrants.

Clear Street Group Inc. filed an S-1/A for its initial public offering, targeting a $40.00-$44.00 per share price and highlighting significant revenue and net income growth, alongside strategic acquisitions and platform expansion.

Liminatus Pharma, a pre-clinical stage biopharmaceutical company, is offering up to 6.9 million shares and 10.3 million warrants to fund its CD47 immune checkpoint inhibitor development, despite significant losses and Nasdaq compliance issues.

Veri Medtech Holdings, Inc. filed an S-1/A registration statement for a firm commitment public offering of common stock, seeking capital while reporting significant net losses and a going concern doubt.

BioRestorative Therapies, Inc. filed an S-1/A amendment to include a Placement Agency Agreement and a revised filing fee table for its proposed public offering of securities.

Little West Holdings Inc. has filed an amended registration statement for its initial public offering, detailing underwriting terms, executive compensation, and existing financial agreements.

Rubber Leaf Inc. files for a 5 million share IPO at $4 per share, seeking Nasdaq listing after restructuring operations to Hong Kong and divesting its PRC subsidiary.

Brookline Capital Acquisition Corp II, a SPAC targeting healthcare and defense technology, filed an S-1/A for a $100 million IPO, emphasizing experienced management and a focus on established, profitable companies.

JOSS Realty REIT, Inc. filed an S-11/A for its initial public offering of 3 million shares, aiming to raise $10.75 million, despite recurring net losses and substantial doubt about its ability to continue as a going concern.

AIM ImmunoTech Inc. files an S-1/A for a rights offering to raise capital through the distribution of units comprising Series G Convertible Preferred Stock and Class G Common Stock Purchase Warrants to existing shareholders and warrant/option holders.

TV Channels Network Inc., a development-stage streaming company with no revenue, is launching an IPO at $4.00 per share despite auditors raising substantial doubt about its ability to continue as a going concern.

Karbon-X Corp. filed an S-1/A amendment to include an updated auditor's consent, which highlights substantial doubt about the company's ability to continue as a going concern.

Nuburu, Inc. is undergoing a significant strategic shift from blue laser manufacturing to defense technology and operational resilience, marked by recent acquisitions and a public offering, despite persistent operating losses and substantial doubt about its ability to continue as a going concern.

Amatuhi Holdings, a Japanese operator of disability group homes, plans an initial public offering of 3 million shares on Nasdaq to fund its aggressive expansion strategy in a high-demand market.

Clear Street Group Inc. is proceeding with its initial public offering, aiming to raise up to $1.06 billion, following significant revenue and net income growth in 2024 and 2025.

Envoy Medical, Inc. has amended its engagement letter with H.C. Wainwright & Co., LLC, adjusting fees and extending the term for a registered equity offering aiming to raise at least $30 million.

BioRestorative Therapies is offering up to 9.7 million units, aiming to raise $10 million to fund clinical trials and R&D, amidst ongoing substantial losses and going concern doubts.

Nightfood Holdings files S-1 for resale of 150M common shares, highlighting strategic shift to AI robotics and hospitality amidst significant losses and going concern doubt.

Movano Inc. filed an S-1/A detailing its planned reverse merger with AI cloud computing firm Corvex Inc. and a committed equity facility of up to $1 billion with Chardan Capital Markets LLC, while addressing Nasdaq listing compliance issues.

Karbon-X Corp. filed an amendment to its S-1 registration statement, primarily to update its auditor's consent, which includes an emphasis of matter regarding substantial doubt about the company's ability to continue as a going concern.

Twenty One Capital, Inc. filed an S-1/A registration statement for the resale of up to $464 million in 1.00% convertible senior notes due 2030 and underlying Class A common stock, following its business combination.

Charging Robotics Inc. filed an S-1/A to include an auditor's consent, update estimated offering expenses, and detail recent unregistered securities sales.

Society Pass Incorporated is offering up to 4.38 million shares of common stock and pre-funded warrants to raise approximately $9.1 million for working capital, while facing recurring losses and significant litigation judgments.